Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Tourmaline Bio is well-funded, with cash runway into 2H 2027, minimizing near-term dilution risk for investors. Click here to ...

The global Burn Care Market is projected to be valued at USD 2.79 billion in 2024 and reach US$ 4.23 billion by 2030, growing ...

Given this risk, we thought we'd take a look at whether MDJM (NASDAQ:UOKA) shareholders should be worried about its cash burn ...

With an expanded product portfolio, Avita Medical is on a concerted US push to win market share and become profitable by the end of the year ...

Shares of biotechnology company Prime Medicine, Inc. (PRME) fell 18% on Monday afternoon after the company announced a ...

Allan Reine, the company's chief financial officer, has been named CEO and will become a member of the board. Jeff Marrazzo, another director, has been named executive chair. Prime's shares fell 8.2% ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. Given this risk, we thought we'd take a look at whether XBiotech (NASDAQ:XBIT) shareholders ...